N G Morgenthaler
Role of RAS inhibition in the regulation of Cu/Zn-SOD in the cardiac and peripheral arterial beds in humans
Kuster G, Rickli H, Riesen W, Rüter F, Morgenthaler N, Mueller B, Schuetz P, Bernheim A, Schindler R, Kiowski W, Nietlispach F, Brunner-La Rocca H. Role of RAS inhibition in the regulation of Cu/Zn-SOD in the cardiac and peripheral arterial beds in humans. Clin Pharmacol Ther 2010; 87:686-92.
May 5, 2010Role of RAS inhibition in the regulation of Cu/Zn-SOD in the cardiac and peripheral arterial beds in humans
May 5, 2010Clin Pharmacol Ther 2010; 87:686-92
Kuster G M, Rickli Hans, Riesen W, Rüter F, Morgenthaler N G, Mueller B, Schuetz P, Bernheim A, Schindler R, Kiowski W, Nietlispach F, Brunner-La Rocca H P
B-type natriuretic peptide and C-terminal-pro-endothelin-1 for the prediction of severely impaired peak oxygen consumption
Maeder M, Potocki M, Reichlin T, Klima T, Christ A, Breidthardt T, Laule K, Noveanu M, Bergmann A, Morgenthaler N, Staub D, Brutsche M, Mueller C. B-type natriuretic peptide and C-terminal-pro-endothelin-1 for the prediction of severely impaired peak oxygen consumption. Journal of internal medicine 2009; 265:604-15.
May 1, 2009B-type natriuretic peptide and C-terminal-pro-endothelin-1 for the prediction of severely impaired peak oxygen consumption
May 1, 2009Journal of internal medicine 2009; 265:604-15
Maeder Micha, Potocki M, Reichlin T, Klima T, Christ A, Breidthardt T, Laule K, Noveanu M, Bergmann A, Morgenthaler N G, Staub D, Brutsche Martin, Mueller C